Actively Recruiting

Phase 1
Phase 2
Age: 55Years +
All Genders
NCT07161726

Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial

Led by University of Alabama at Birmingham · Updated on 2026-05-08

36

Participants Needed

1

Research Sites

88 weeks

Total Duration

On this page

Sponsors

U

University of Alabama at Birmingham

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of the study is to see if regular exercise when combined with a cocoa supplement will improve physical performance and muscle strength compared to regular exercise alone.

CONDITIONS

Official Title

Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial

Who Can Participate

Age: 55Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 55 years and older
  • Slow walking speed of less than 1 meter per second
  • Willingness to be randomly assigned to either treatment group
  • Willingness to participate in all study procedures (muscle biopsy is optional)
Not Eligible

You will not qualify if you...

  • Unable to provide informed consent
  • Regular use of flavanol or cocoa supplements
  • Participation in a supervised rehabilitation or exercise program
  • Absolute contraindications to exercise training per American College of Sports Medicine guidelines
  • Daytime systolic blood pressure of 180/100 mm Hg or higher
  • Refusal to stop blood thinners like baby aspirin
  • Peripheral vascular disease, peripheral neuropathy, or retinopathy
  • Severe cardiac disease including advanced heart failure, significant aortic stenosis, history of cardiac arrest, use of a defibrillator, or uncontrolled angina
  • Heart attack or stroke within the past year
  • Significant cognitive impairment or dementia (Mini-Mental State Exam score below 24)
  • Progressive neurological diseases such as Parkinson's or multiple sclerosis
  • Severe rheumatologic or orthopedic diseases, including recent joint replacement or active inflammatory disease
  • Severe lung disease requiring steroids or supplemental oxygen
  • Hip fracture, hip/knee replacement, or spinal surgery within the past 4 months
  • Other serious conditions impairing exercise participation
  • Participation in another interventional trial

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

Actively Recruiting

Loading map...

Research Team

R

Robert T Mankowski, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here